Editor’s EmulsionPatient Safety Capsules Drug Laws & Policy Injections Pharma Injections DRUG DOPES National Injections Global Injections PSAIIF Pill
DOSE OF THE DAY FAQ Subscriber's Symptom UpComing Events Laughter Dose Blog Addict Contact Us
EDITOR'S EMULSION
Warm Greetings!!!
Welcome to yet another most pleasant Reading of our newsletter.
It is always my privilege to reach you on 1st & 17th of every month, since the last 11 years. Please do not hesitate to share your comments on this edition to enable us to constantly improve. Please feel free to get in touch with us. You may find our previous issues on our website jagograhakjago.com or in the NEWS ARCHIVE section of every issue of The Prescription, in case you’ve missed any of them. You may also look us up on Facebook.
Stay Healthy. Stay Protected.
Pyush Misra
Editor-in-Chief
DOSE OF THE DAY
The COVID-19 pandemic has disrupted delivery of cancer care services including palliative care. This has further exposed the vulnerabilities of people living with cancers and increased the risk of severe disease and death. We need to urgently address these gaps.
As countries build back and reprioritize public spending, we have an opportunity to focus on providing equitable access to tools for early detection, diagnosis, treatment and palliative care to ensure a fairer future where everyone can live happier, healthier lives leaving no one behind.
Dr. Poonam Khetrapal Singh
Regional Director,
WHO South East Asia
Sponsor
Patient Safety Capsules
Trade Margin Rationalisation- Need for a rational way forward: Prof Bejon Kumar Misra
New Delhi, February 11, 2022: There is an urgent need to ensure citizens are enabled to access quality healthcare, especially medicines in India. In order to improve accessibility and affordability, Government must consider major changes in the pricing policy of medicines in our country.
Ayush Ministry Releases New National List Of Essential Ayush Medicines
New Delhi, February 8, 2022: The Union Ministry of Ayush has released the National List of Essential Ayush Medicines (NLEAM), by including the generic medicines from pharmacopeia formulary and authoritative texts, as a reference guide for the manufacturing and procurement and supply of classical medicines in both the public and private sector.
Drug Laws & Policy Injections
Maha FDA asks manufacturers to speed up Class A & B medical device registration with CDSCOMumbai, February 15, 2022: Even as registration of Class A and Class B medical devices with the Central Drugs Standard Control Organization (CDSCO) became mandatory from October 1, 2021, it has received a lukewarm response from device manufacturers. Taking serious note of this, Maharashtra food and drug administration (FDA) has directed manufacturers of medical devices falling under Class A and Class B in the state to speed up registration with the CDSCO.
Ministry of Ayush amends law to appoint part-time members of National Commission of Indian System of Medicine New Delhi, February 16, 2022: The Ministry of Ayush has initiated steps to fill in the seats of the part-time members of National Commission of Indian System of Medicine even if no nominees of the States and Union Territories (UTs) are available, on first come first appointment basis. A similar step has been initiated for the National Commission for Homoeopathy too, through a separate notification by the ministry.
Health ministry to direct PCI to implement DPEE Regulations to weed out fake diploma certificatesChennai, February 16, 2022: The Union health ministry is learnt to have taken a decision to implement the D Pharm Exit Examination (DPEE) Regulations 2018 across the country in order to weed out fake diploma certificates from getting registered with state pharmacy councils.
Experts expect government to set up local honey testing labsNew Delhi, February 11, 2022: Well -known experts from that side of the honey industry have stressed the importance of setting up honey testing facilities by the government, better training, facilities and services. with capacity building for beekeepers. In order to promote cattle management in India and create a better environment, experts have looked at ways of cooperation and support from the government for the overall growth of beekeepers, e.g. An important part of the Honey ecosystem. 
Govt said Rs 7,690-cr Covid-19 to pipeline projectsFebruary 10, 2022: After former President Rahul Gandhi trained his guns on Prime Minister Narendra Modi for PM Cares ’lack of funding, the Center explained on Friday that some actions had been allowed to pay off. Posted by PM Cares.
DGFT lifts ban on export of syringesMumbai, Ferbruary 2, 2022: The Directorate General of Foreign Trade (DGFT) has opened restrictions on the importation of syringes with immediate effect following the request of the health sector.
Pharma Injections
Indian pharma sees immense relevance to US FDA guidance on population pharmacokinetics for NDAsBengaluru, February 12, 2022: Indian pharma companies sees immense relevance to the recently issued US FDA guidance on population pharmacokinetics for new drug applications (NDAs). The industry is of the view that with the accelerated investments in R&D, NDAs could be a reality.
CDSCO declares 27 out of 1,227 drug samples tested as not of standard qualityNew Delhi, February 11, 2022: The Central Drugs Standard Control Organisation (CDSCO) has declared that a little over two percent of the drug samples it has tested during the month of January 22, through various Central Drugs Laboratories in the country as not of standard quality, while there were no spurious or misbranded drugs among the samples tested.
ICMR launches online portal to streamline submission of clinical trial applications for gene therapy Mumbai, February 14, 2022: The Indian Council of Medical Research (ICMR), the apex body in India for the formulation, coordination and promotion of biomedical research, has launched online portal of Gene Therapy Advisory and Evaluation Committee (GTAEC) aiming to streamline submission of clinical trial applications and pre-IND consultations pertaining to gene therapy research in the country.
Zydus gets USFDA approval to sell Roflumilast tablets Ahmedabad, February 14, 2022: Zydus Pharmaceuticals Inc. has acquired. final approval from the USFDA to sell Roflumilast Tablets in a strength of 500 mcg. This comes with approval for Roflumilast Tablets in a strength of 250 mcg, generic bioequivalent to Reference Listed Drug Daliresp.
New antibody helps block Covid transmission in cells: Study New Delhi, February 14, 2022: Researchers have engineered a novel antibody that can directly interfere with and block the cell-to-cell transmission ability of SARS-CoV-2, the virus that causes COVID-19.
Covid Oral Pill first saw sales of just ₹ 46cr in January Mumbai, February 14, 2022: Molnupiravir, the first oral antiviral for the treatment of chronic kidney disease and low Covid approved by the US Food and Drug Administration (FDA), seems to have exploded in the local market. This is very different than the first two waves when Covid drugs registered phenomenal sales.
Drug Dopes
0.31% of drug samples tested in 2020-21 declared as spurious or adulteratedNew Delhi, February 15, 2022: In a year when the country has seen challenges in various levels due to Covid-19 pandemic and its impact on various walks of life, various drug control authorities in the country have seen a slight increase in spurious and adulterated drugs in the sample tests across the country in 2020-21, according to data. 
Number of Ayush drug manufacturing units decline 9% in 10 yearsNew Delhi, February 16, 2022: The number of original licensed Ayush drug manufacturing units in the country has declined around nine per cent in ten years till 2020, from 8,896 units in 2011 to 8,104 in the year 2020. Almost 94.73 per cent of the total 8,104 original licensed Ayush drug manufacturing units are complied with good manufacturing practices (GMP), according to data from the Ministry of Ayush.
Pharmacists oppose health ministry’s draft amendment to MDR-2017 allowing class12th pass outs to sell medical devices Mumbai, February 16, 2022: Scores of pharmacists have opposed the Union ministry of health and family welfare’s draft amendment to Medical Devices Rules, 2017 allowing non pharmacists who are just class 12th pass outs to stock and sell medical devices, saying that it will have detrimental impact on public health.
The first plasma bank closed the store due to declining demand New Delhi, February 14, 2022: With blood plasma not being used to treat Covid-19 patients these days, plasma reservoirs in the city are closed or are being used to the limit to treat patients. other diseases.
First Procedure in India Performed with Intellis Rechargeable Spinal Cord Stimulator for Chronic Pain Management February 15, 2022: India Medtronic, a wholly owned subsidiary of Medtronic, announced the first clinical procedure in India with the Intellis Spinal Cord Stimulation (SCS) platform, the smallest SCS device for the management of certain types of intractable chronic pain. Dr. Paresh Doshi, Director of Neurosurgery at Jaslok Hospital and Research Center in Mumbai, has successfully implanted the first Intellis device in a patient in India for pain management.
NMC upholds Chinese travel rules, teaches e-medic coursesNew Delhi, February 11, 2022: Looking at some Chinese schools issuing applications for admission to MBBS courses for the coming school years and years, the National Medical Commission has advised students to apply It aims to make the necessary assess-ments and ensure that China continues to impose travel restrictions. after Covid-19. The NMC, which oversees health education in the country, also explained that it will not see online medical courses, after Chinese officials told students that they would be classes will be led.
National Injections
Maha FDA asks manufacturers to speed up Class A & B medical device registration with CDSCO Mumbai, February 15, 2022: Even as registration of Class A and Class B medical devices with the Central Drugs Standard Control Organization (CDSCO) became mandatory from October 1, 2021, it has received a lukewarm response from device manufacturers. Taking serious note of this, Maharashtra food and drug administration (FDA) has directed manufacturers of medical devices falling under Class A and Class B in the state to speed up registration with the CDSCO.
Kerala DCA could not detect violation of laws by a medical shop at Kozhikodu for four yearsChennai, February 14, 2022: The recent violation detection, unearthed by the Kozhikodu zonal intelligence wing of the Kerala drugs control administration that a medical shop was operating without a registered pharmacist for the last four years, shows the regulatory body’s inefficiency and poor performance with regard to enforcement of Drugs and Cosmetics Laws in the state.
Telangana govt to spend Rs. 86.90 crore to set up paediatric ICUs in all 33 district hospitals in the state Hyderabad, February 12, 2022: The state government of Telangana has decided to spend Rs. 86.90 crore for setting up of paediatric intensive care units (PICUs) in all the 33 district hospitals in the state.
By lowering COVID-19 curbs, Maharashtra health minister stressed the need to wear a mask Mumbai, February 10, 2022: Maharashtra Health Minister Rajesh Tope said on Friday that the state government has appeased COVID-19 detai-nees in the past, but people should continue to wear face masks and follow the rules. do something else. Speaking to reporters in Kolhapur, Tope also said the curbs should not be imposed again in the coming days.
Investing in maternal health and nutrition is essential for India February 10, 2022: According to the Global Nutrition Report 2021, India’s progress in maternal health and nutrition needs to be accele-rated. The latest National Family Health Survey (NFHS-5 2019-20) also indicates that the percentage of anemic women has increased to around 57%, raising concerns.
AIIMS has named the team to help Jaya Death Probe Panel CHENNAI, February 10, 2022: The All India Institute of Medical Science (AIIMS) has set up eight medical staff to assist the Justice A Arumughaswamy Commission which is investigating the circumstances leading up to the death of former prime minister J Jayalalithaa, to as directed by the Film Board.
Global Injections
As CDC Holds the Line, Doctors Debate Lifting Mask MandatesFebruary 11, 2022: New COVID-19 case numbers in the United States have dropped nearly two thirds from just weeks ago, and the drop has set off heated conversations across the United States on when and if mask mandates should stop.
FDA wallops Indian drugmaker with warning letter blasting API quality, equipment cleanliness and moreFebruary 15, 2022: What not to do with active pharmaceutical ingredient (API) batch records? Tear them out of a company logbook ahead of an FDA inspection, for one. Earlier this month, Indian drugmaker Indiana Chem-Port learned that lesson the hard way.
ASCO GU: Amgen's Lumakras posts encouraging results in pancreatic cancer, though not as dazzling as Mirati rival
February 15, 2022: In Amgen’s battle with Mirati Therapeutics to develop the best KRAS inhibitor, the biotech giant may have reached the FDA finish line first. But Mirati's rival drug seems to carry clinical advantages of its own.
China approves use of Pfizer’s COVID drug Paxlovid
February 12, 2022: China’s health product regulator said on Saturday it has given approval for Pfizer’s COVID-19 drug Pax-lovid, making it the first oral pill developed to treat cleft lip and palate. in the country.
EU, Gates Foundation to spend over 100 million euros to set up African drug regulator
BRUSSELS, February 16, 2022: The European Union and the Gates Foundation will spend over 100 million euros ($ 113.4 million) over the next five years to help establish an African pharmaceutical company to promote medicines. treatment and management of the disease, the EU Commission said on Tuesday.
Long COVID Symptoms Linked to Effects on Vagus Nerve
Febraury 15, 2022: Several long COVID symptoms could be linked to the effects of the coronavirus on a vital central nerve, according to new research being released this spring.
PSAIIF PILL
Commerce ministry recommends continuation of anti-dumping duty on import of amoxycillin from China
Mumbai, February 17, 2022: The Union commerce ministry has recommended the continuation of anti-dumping duty on semi synthetic antibiotic drug amoxycillin trihydrate imported from China for five years in order to protect domestic manufacturers from cheap imports.
Researchers develop novel fluorometric detection technology to spot pathogens including Covid-19
Bengaluru, February 11, 2022: The Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) and the Indian Institute of Science (IISc) in a joint research initiative have developed a novel technology to detect pathogens including viruses though fluorometric detection by measuring the fluorescent light emitted by the pathogens.
Frequently Asked Questions
What Can Wordle Do for Our Brains?
Forget morning coffee, stretches, or meditation. There's a new way to kick-start your brain. Jeanenne Ray, a book editor in Marin County, CA, tackles it first thing in the morning, while still lying in bed. It's also the first on the to-do list of Shelly Groves, who owns a dog walking and pet sitting service in Avondale Estates, GA. That's also the pattern of Todd Siesky, an Atlanta communications professional, but he knows to walk away if it gets too frustrating. Read More>>>
SUBSCRIBER'S SYMPTOM
Blood pressure warning over long-term paracetamol use
February 8, 2022: People with high blood pressure who take paracetamol on prescription could be increasing their risk of heart attacks and strokes, a study suggests. Doctors should think about the risks and benefits to patients taking it over many months, the University of Edinburgh researchers say.
Consumer Online Foundation: The first and only organisation certified as per international standard ISO 9001:2015 for Consumer Complaint Redressal Services
First and the only organization in India to be certified on 21st September 2021 as an ISO 9001:2015 on Consumer Complaint Redressal Services. We are proud to share our achievements with our readers and supporters. Thanks for your continued support and guidance for more than 35+ years of service to the consumers in India and abroad.
Blog Addicts
Ms. Aarohi, Haridwar It's awesome, really, I can't say enough about how well it's tailored to cover healthcare news from all around..
Ms. Shahina Saba, KolkataThank you for all of your hard work and dedication in publishing such an updated newsletter.
Mr. Jagdish Tyagi, Gaya
I love the approachable format and the articles that PSAI choses to feature in their Newsletter. Good work, Keep it up!
This Newsletter is brought to you by
Patient Safety And Access Initiative of India Foundation
B306, First Floor, C R Park, New Delhi -110019
jagograhakjago.com; www.jagograhakjago.com;
Disclaimer : Our newsletter endeavors to compile patient safety information from various sources .
PSAIIF may not be held responsible for any article published in The Prescription.
